CHICAGO (Reuters) - The Food and Drug Administration on Wednesday said the rising number of cosmetics, drugs and other products made using nanotechnology do not require special regulations or labeling.

The recommendations come as the agency looks at the oversight of products that employ the design and use of particles as small as one-billionth of a meter. There are fears by consumer groups and others that these tiny particles are unpredictable, could be toxic and therefore have unforeseen health impacts.

A task force within the FDA concluded that although nano-sized materials may have completely different properties than their bigger counterparts, there is no evidence...READ ON>>>